MDT vs PATH · P/E 21, rev $36.36B vs P/E 19, rev $1.61B
Medtronic PLC (MDT) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Medtronic PLC (MDT) is a medical devices company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported MDT revenue for 2026-04-24 was $36.36B. Net income was $4.80B. Revenue was up 8.4% from 2025-04-25 to 2026-04-24. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
MDT currently screens at market cap $100.08B and trailing P/E 20.9. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the MDT and PATH stock pages for the full models.
Not investment advice.